Literature DB >> 25202097

A dosimetric analysis of intensity-modulated radiation therapy with bone marrow sparing for cervical cancer.

Naoya Murakami1, Hiroyuki Okamoto2, Takahiro Kasamatsu3, Kazuma Kobayashi2, Ken Harada2, Mayuka Kitaguchi2, Shuhei Sekii2, Kana Takahashi2, Kotaro Yoshio2, Koji Inaba2, Madoka Morota2, Minako Sumi2, Takafumi Toita4, Yoshinori Ito2, Jun Itami2.   

Abstract

BACKGROUND/AIM: The purpose of the present study was to compare intensity-modulated radiation therapy (IMRT) plan with (Bone Marrow Sparing (BMS) - IMRT) or without (normal-IMRT) an intention of avoiding bone marrow in order to minimize treatment-related toxicity. PATIENTS AND METHODS: Computed tomography (CT) images of 10 consecutive postoperative cervical cancer patients were used. All patients were already treated by normal-IMRT. BMS-IMRTs were created for this study and dose-volume histogram parameters were compared.
RESULTS: Both planning target volume (PTV) D95% and D97% were statistically lower in BMS-IMRT than normal-IMRT, however, the difference was lower than 3%. There were no statistical differences between BMS-IMRT and normal-IMRT in the mean value of rectum V30Gy, V50Gy; bladder V45Gy, V50Gy; Bowel V35Gy, and V50Gy. Both in whole pelvic bone (WPB) and inner cavity of pelvic bone (ICPB), the mean value of V10Gy, V30Gy, and V40Gy of BMS-IMRT were statistically lower than that of normal-IMRT.
CONCLUSION: Both lower and higher dose for WPB as well as ICPB were effectively lowered by BMS-IMRT. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Cervical cancer; IMRT; bone marrow sparing; postoperative radiation therapy; radical hysterectomy

Mesh:

Year:  2014        PMID: 25202097

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  Approach to radiation therapy in the Jehovah's Witness patient: An overview.

Authors:  James M Jurica; Jay A Messer; Bin S Teh; Brian E Butler; Andrew M Farach
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-25

2.  Impact of different optimization strategies on the compatibility between planned and delivered doses during radiation therapy of cervical cancer.

Authors:  Agata Jodda; Tomasz Piotrowski; Marta Kruszyna-Mochalska; Julian Malicki
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-12

3.  Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients.

Authors:  Keisuke Tsuchida; Naoya Murakami; Tomoyasu Kato; Kae Okuma; Hiroyuki Okamoto; Tairo Kashihara; Kana Takahashi; Koji Inaba; Hiroshi Igaki; Yuko Nakayama; Takashi Nakano; Jun Itami
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

4.  Lymphocyte-sparing pelvic radiotherapy for prostate cancer: An in-silico study.

Authors:  Mathilde Baré; Sara Poeta; Patricia Fernandes; Younes Jourani; François-Xavier Otte; Sara Van Brussel; Dirk Van Gestel; Robbe Van den Begin
Journal:  Phys Imaging Radiat Oncol       Date:  2022-07-30

5.  Kidney-Sparing Methods for Extended-Field Intensity-Modulated Radiotherapy (EF-IMRT) in Cervical Carcinoma Treatment.

Authors:  Hiroaki Kunogi; Nanae Yamaguchi; Yasuhisa Terao; Keisuke Sasai
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.